Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 1
Submit an article Journal homepage
97
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Validation of an administrative coding algorithm for the identification of individuals with amyloid light chain amyloidosis using administrative data

Victor H. Jimenez-Zepedaa Department of Medical Oncology and Hematology, Tom Baker Cancer Centre, Calgary, CanadaView further author information
,
Donna Reeceb Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, CanadaView further author information
,
Rodrigo Rigoc Oncology Outcomes Research Initiative, University of Calgary, Calgary, Canada;d Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, CanadaView further author information
,
Priyanka Gognac Oncology Outcomes Research Initiative, University of Calgary, Calgary, Canada;e Department of Public Health Sciences, Queen’s University, Kingston, CanadaView further author information
,
Shiying Kongc Oncology Outcomes Research Initiative, University of Calgary, Calgary, Canada;d Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada;f Department of Community Health Science, University of Calgary, Calgary, CanadaView further author information
,
Xun Yang Huc Oncology Outcomes Research Initiative, University of Calgary, Calgary, Canada;d Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, CanadaView further author information
,
Parv Chapanic Oncology Outcomes Research Initiative, University of Calgary, Calgary, Canada;d Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, CanadaORCID Iconhttps://orcid.org/0000-0002-0306-6756View further author information
ORCID Icon,
Winson Y. Cheungc Oncology Outcomes Research Initiative, University of Calgary, Calgary, Canada;d Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada;g Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, CanadaView further author information
,
Darren R. Brennerc Oncology Outcomes Research Initiative, University of Calgary, Calgary, Canada;d Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada;f Department of Community Health Science, University of Calgary, Calgary, CanadaView further author information
,
Richard Planteh Janssen Medical Affairs, Toronto, CanadaView further author information
,
Kun Shii Janssen Market Access, Toronto, CanadaView further author information
,
Asad Husaini Janssen Market Access, Toronto, CanadaView further author information
,
Eric Ammannj Janssen Global Market Access, Raritan, NJ, USAORCID Iconhttps://orcid.org/0000-0001-5882-5388View further author information
ORCID Icon,
Dipti Tankalai Janssen Market Access, Toronto, CanadaView further author information
&
Devon J. Boynec Oncology Outcomes Research Initiative, University of Calgary, Calgary, Canada;d Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, CanadaCorrespondencedevon.boyne1@ucalgary
ORCID Iconhttps://orcid.org/0000-0001-6301-2429View further author information
ORCID Icon show all
Pages 256-258 | Received 25 Aug 2022, Accepted 08 Oct 2022, Published online: 21 Nov 2022
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure of interest

Victor H Jimenez-Zepeda received honoraria from Janssen Inc. Donna Reece received honoraria and research funding from Janssen Inc. Rodrigo Rigo, Priyanka Gogna, Shiying Kong, Xun Yang Hu, Parv Chapani, Winson Y Cheung, Darren R Brenner, Devon J Boyne are team members of Oncology Outcomes which received research funding from Janssen Inc. Richard Plante, Kun Shi, Asad Husain, Eric Ammann, Dipti Tankala are employees of Janssen Inc. Eric Amman owns shares in Janssen Inc.

Additional information

Funding

This study was funded by Janssen.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.